Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

NDT-19795

Copy Product Info
😃Good
Catalog No. T86987Cas No. 2272917-12-9
Alias NDT-19795, NDT19795, NDT 19795

NDT-19795 is an effective small-molecule inhibitor of the NLRP3 inflammasome with IC50 values of 66 nM in PBMC-based assays and 4.7 μM in western blot analyses, functioning as a carboxylic acid–active metabolite derived intracellularly from NT-0796, and supporting research into neuroinflammation and neurological disease mechanisms.

NDT-19795

NDT-19795

Copy Product Info
😃Good
Catalog No. T86987Alias NDT-19795, NDT19795, NDT 19795Cas No. 2272917-12-9
NDT-19795 is an effective small-molecule inhibitor of the NLRP3 inflammasome with IC50 values of 66 nM in PBMC-based assays and 4.7 μM in western blot analyses, functioning as a carboxylic acid–active metabolite derived intracellularly from NT-0796, and supporting research into neuroinflammation and neurological disease mechanisms.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$9810-14 weeks10-14 weeks
5 mgPreferential-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
NDT-19795 is an effective small-molecule inhibitor of the NLRP3 inflammasome with IC50 values of 66 nM in PBMC-based assays and 4.7 μM in western blot analyses, functioning as a carboxylic acid–active metabolite derived intracellularly from NT-0796, and supporting research into neuroinflammation and neurological disease mechanisms.
Targets&IC50
NLRP3:66 nM
In vivo
Method: NDT-19795 was administered intravenously at 3 mg/kg as a single dose in C57BL/6 mice.
Result: NDT-19795 showed a low brain-to-blood ratio of 0.07, indicating limited BBB penetration[1].
SynonymsNDT-19795, NDT19795, NDT 19795
Chemical Properties
Molecular Weight367.4
FormulaC20H21N3O4
Cas No.2272917-12-9
SmilesN(C(O[C@H](CC=1N=CC=CN1)C(O)=O)=O)C2=C3C(=CC4=C2CCC4)CCC3
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 80.00 mg/mL (217.75 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.7218 mL13.6091 mL27.2183 mL136.0915 mL
5 mM0.5444 mL2.7218 mL5.4437 mL27.2183 mL
10 mM0.2722 mL1.3609 mL2.7218 mL13.6091 mL
20 mM0.1361 mL0.6805 mL1.3609 mL6.8046 mL
50 mM0.0544 mL0.2722 mL0.5444 mL2.7218 mL
100 mM0.0272 mL0.1361 mL0.2722 mL1.3609 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy NDT-19795 | purchase NDT-19795 | NDT-19795 cost | order NDT-19795 | NDT-19795 chemical structure | NDT-19795 in vivo | NDT-19795 formula | NDT-19795 molecular weight